Return to Play, Performance, and Economic Analysis of National Football League Players After Lisfranc Injury.
Lisfranc
NFL
National Football League
foot
Journal
Orthopaedic journal of sports medicine
ISSN: 2325-9671
Titre abrégé: Orthop J Sports Med
Pays: United States
ID NLM: 101620522
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
received:
20
12
2022
accepted:
19
01
2023
medline:
15
4
2023
entrez:
14
4
2023
pubmed:
15
4
2023
Statut:
epublish
Résumé
A Lisfranc injury can occur to either the ligament or bone, which causes instability when attempting to perform strength and balance maneuvers. The study's aims were to (1) analyze the return-to-play (RTP) rate and performance level of players in the National Football League (NFL) after Lisfranc injury and (2) determine the economic and financial impact of Lisfranc injuries to the NFL. We hypothesized that there would be a low RTP rate following Lisfranc injury in the NFL. Case series; Level of evidence, 4. Multiple online public records were used to identify NFL players with Lisfranc injuries between the 2009 and 2020 seasons. Players were assessed according to their RTP statistics: snap count, approximate value (AV), games played, and games started. Nonparametric methods were used to compare player statistics before and after injury. Also, player salaries while injured were calculated (in 2022 US dollars after adjusting for inflation) to approximate economic loss for those players who returned to play. A total of 33 NFL athletes sustained a Lisfranc injury during the study period. Most Lisfranc injuries were experienced by offensive linemen (n = 8; 24.2%), followed by running backs (n = 7; 21.2%). Overall 27 players (81.8%) returned to play after injury at a median of 11.0 months (IQR, 10.2-11.8 months). There were no significant differences between pre- and postinjury snap counts or number of games played and started. In terms of player performance, there was a statistically significant decrease in AV at 1 year postinjury (median [IQR], 6.0 [4.0-10.0] preinjury vs 5.0 [2.5-7.5] postinjury; Our results did not support the hypothesis, as the RTP rate for NFL athletes sustaining Lisfranc injuries was 81.8%. This injury was associated with a significant decrease in AV 1 year postinjury. In terms of economic impact, quarterbacks accounted for almost one-third of expenses while constituting only 14.8% of injuries.
Sections du résumé
Background
UNASSIGNED
A Lisfranc injury can occur to either the ligament or bone, which causes instability when attempting to perform strength and balance maneuvers.
Purpose/Hypothesis
UNASSIGNED
The study's aims were to (1) analyze the return-to-play (RTP) rate and performance level of players in the National Football League (NFL) after Lisfranc injury and (2) determine the economic and financial impact of Lisfranc injuries to the NFL. We hypothesized that there would be a low RTP rate following Lisfranc injury in the NFL.
Study Design
UNASSIGNED
Case series; Level of evidence, 4.
Methods
UNASSIGNED
Multiple online public records were used to identify NFL players with Lisfranc injuries between the 2009 and 2020 seasons. Players were assessed according to their RTP statistics: snap count, approximate value (AV), games played, and games started. Nonparametric methods were used to compare player statistics before and after injury. Also, player salaries while injured were calculated (in 2022 US dollars after adjusting for inflation) to approximate economic loss for those players who returned to play.
Results
UNASSIGNED
A total of 33 NFL athletes sustained a Lisfranc injury during the study period. Most Lisfranc injuries were experienced by offensive linemen (n = 8; 24.2%), followed by running backs (n = 7; 21.2%). Overall 27 players (81.8%) returned to play after injury at a median of 11.0 months (IQR, 10.2-11.8 months). There were no significant differences between pre- and postinjury snap counts or number of games played and started. In terms of player performance, there was a statistically significant decrease in AV at 1 year postinjury (median [IQR], 6.0 [4.0-10.0] preinjury vs 5.0 [2.5-7.5] postinjury;
Conclusion
UNASSIGNED
Our results did not support the hypothesis, as the RTP rate for NFL athletes sustaining Lisfranc injuries was 81.8%. This injury was associated with a significant decrease in AV 1 year postinjury. In terms of economic impact, quarterbacks accounted for almost one-third of expenses while constituting only 14.8% of injuries.
Identifiants
pubmed: 37056454
doi: 10.1177/23259671231159935
pii: 10.1177_23259671231159935
pmc: PMC10087650
doi:
Types de publication
Journal Article
Langues
eng
Pagination
23259671231159935Informations de copyright
© The Author(s) 2023.
Déclaration de conflit d'intérêts
One or more of the authors has declared the following potential conflict of interest or source of funding: A.V.S. has received grant support from Arthrex; education payments from Arthrex, Legacy Ortho, Smith & Nephew, and Stryker; nonconsulting fees from Smith & Nephew; and hospitality payments from Wright Medical. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.
Références
J Strength Cond Res. 2018 Nov;32(11):3119-3126
pubmed: 30540280
Orthopedics. 2018 Jul 1;41(4):e479-e482
pubmed: 29708569
Am J Sports Med. 2017 Jul;45(8):1901-1908
pubmed: 28350487
Orthop J Sports Med. 2022 Jun 21;10(6):23259671221102969
pubmed: 35757241
Int J Physiol Pathophysiol Pharmacol. 2022 Jun 15;14(3):161-170
pubmed: 35891929
Arthroscopy. 2018 Jun;34(6):1809-1815
pubmed: 29482860
Am J Sports Med. 2016 Jul;44(7):1810-7
pubmed: 27166291
J Shoulder Elbow Surg. 2017 Feb;26(2):288-294
pubmed: 28104091
J Shoulder Elbow Surg. 2020 Jan;29(1):121-125
pubmed: 31668501
Orthop J Sports Med. 2021 Sep 03;9(9):23259671211025305
pubmed: 34504899
Arthrosc Sports Med Rehabil. 2021 Jul 29;3(5):e1377-e1385
pubmed: 34746844
Am J Sports Med. 2017 Oct;45(12):2864-2871
pubmed: 28644678
Kans J Med. 2019 Nov 25;12(4):141-145
pubmed: 31803357
Orthopedics. 2014 Aug;37(8):e728-34
pubmed: 25102509
Am J Sports Med. 2016 Jan;44(1):166-70
pubmed: 26637283
Sports Med. 2018 Jan;48(1):45-55
pubmed: 28948583
Orthop J Sports Med. 2022 Mar 7;10(3):23259671221079637
pubmed: 35284583
Foot Ankle Int. 2018 Jul;39(7):801-807
pubmed: 29606024